Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2012
Context: The filing discloses previously non-public information regarding unaudited revenue and operating results estimates for the fourth quarter of fiscal 2011. This information was presented at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references attached presentation materials (Exhibit 99.1, slides 10, 17, 25, and 26) which contain the unaudited estimates for the fourth quarter of fiscal 2011, but the text of the 8-K itself does not list these figures.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text body. It serves as a disclosure mechanism to release the Q4 2011 estimates to the public in compliance with Regulation FD.
Guidance, Outlook, and Risks
Management Commentary: The company is releasing unaudited estimates for the recently completed fourth quarter of fiscal 2011.
Regulatory Status: The information furnished in this report, including the attached exhibits, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that Section. It shall not be deemed incorporated by reference into any other filing unless specifically identified as such.
Availability: The presentation slides are available on the Company's investor relations website.
Investor Verification Checklist
- Verify the specific unaudited revenue and operating results estimates for Q4 2011 by reviewing Exhibit 99.1 (slides 10, 17, 25, and 26) attached to the filing or posted on the investor relations website.
- Confirm whether the unaudited estimates differ significantly from previously issued guidance or analyst consensus.
- Review the full presentation materials for any updated full-year 2011 guidance or 2012 outlook not captured in the 8-K summary text.